Abstract | OBJECTIVE: METHOD: This study retrospectively analysed the immunolocalization of IGF-1 and IGF-1R in schwannoma specimens collected from all patients with sporadic schwannoma that were treated by two institutions in Japan. The study also evaluated the association between the extent of the IGF-1 and IGF-1R immunoreactivity and several clinicopathological characteristics (age, sex and maximum tumour dimension). RESULTS: The study examined a total of 29 sporadic schwannoma specimens. IGF-1 and IGF-1R immunoreactivity was detected in the majority of the specimens regardless of their anatomical location. IGF-1 and IGF-1R were not co-localized. There was no association between the extent of the IGF-1 and IGF-1R immunoreactivity and the clinicopathological characteristics of the patients. CONCLUSIONS: As IGF-1 and IGF-1R immunoreactivity was detected in the majority of sporadic schwannoma specimens regardless of their anatomical location, these findings suggest that an IGF-1/IGF-1R loop could play a role in the tumorigenesis and progression of schwannomas via an autocrine-paracrine mechanism.
|
Authors | Fumiaki Matsubara, Takuyuki Katabami, Shiko Asai, Yasushi Ariizumi, Ichiro Maeda, Masayuki Takagi, May McNamara Keely, Katsuhiko Ono, Takashi Maekawa, Yasuhiro Nakamura, Yasushi Tanaka, Hironobu Sasano |
Journal | The Journal of international medical research
(J Int Med Res)
Vol. 44
Issue 3
Pg. 662-72
(Jun 2016)
ISSN: 1473-2300 [Electronic] England |
PMID | 27091859
(Publication Type: Journal Article)
|
Copyright | © The Author(s) 2016. |
Chemical References |
- Insulin-Like Growth Factor I
- Receptor, IGF Type 1
|
Topics |
- Demography
- Female
- Humans
- Immunohistochemistry
- Insulin-Like Growth Factor I
(metabolism)
- Male
- Middle Aged
- Nerve Sheath Neoplasms
(metabolism, pathology)
- Neurilemmoma
(metabolism, pathology)
- Receptor, IGF Type 1
(metabolism)
- Retroperitoneal Neoplasms
(metabolism, pathology)
|